# Proto Axiom

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/proto-axiom-pty

- Industry: Biotechnology
- Headquarters: Melbourne, Australia
- Website: www.protoaxiom.com
- Total disclosed funding: $30M
- Latest round: Series B (Aug 13, 2024)
- Investors on record: 11

## About

Founded in 2021, and based in Melbourne, Australia, Proto Axiom Pty Ltd operates as a biomedical technology incubator. Anthony currently serves as the Chief Executive Officer. Previously, he co-found Applecart, the data analytics company in American politics. The Chief Science Officer Lindsay Wu was the head of the laboratory for Ageing Research at UNSW Sydney. In April 2023, Proto Axiom Pty Ltd raised USD 5 million in series A funding from Churchill Asset Management and Riverlane Capital.

The company is engaged in seeking to invest in companies operating in the biotechnology sector. It can license Australia's scientific IP and commercialize it guided by industry advisors and scientific experts.

## Funding rounds

- Series B, Aug 13, 2024, $20M — HOF Capital, Parkview International, Catalio Capital Management, Churchill Asset Management
- Series A, Mar 2, 2023, $2.9M — Churchill Asset Management, Riverlane Capital
- Series A, Sep 16, 2022, $7.2M — HOF Capital, Parkview International, Catalio Capital Management, Time Ventures, Seneca Capital, Reliance Digital Health Limited, Four M Purchasers, Veritatem Kca Consulting Holdings Pty Ltd, N G P Investments No 2 Pty Ltd

## Investors

- HOF Capital (https://capitalatlas.ai/funds/hof-capital) — Series A, Series B
- Parkview International — Series A, Series B
- Catalio Capital Management (https://capitalatlas.ai/funds/catalio-capital-management) — Series A, Series B
- Time Ventures (https://capitalatlas.ai/funds/time-ventures) — Series A
- Seneca Capital (https://capitalatlas.ai/funds/seneca-capital) — Series A
- Reliance Digital Health Limited — Series A
- Four M Purchasers — Series A
- Veritatem Kca Consulting Holdings Pty Ltd — Series A
- N G P Investments No 2 Pty Ltd — Series A
- Churchill Asset Management — Series A, Series B
- Riverlane Capital — Series A